Literature DB >> 2414838

RNA tumor virus in human thymomas and thymus hyperplasias.

A Ono, H Saito, S Kondo, H Yoshimatsu, M Tsuchiya.   

Abstract

Human thymomas and thymus hyperplasias were examined for retroviruses. Most of these patients were complicated by systemic immunological diseases such as myasthenia gravis and pure red cell aplasia. The thymus cells were co-cultured with allogenic B cells or peripheral blood lymphocytes (PBL) pretreated with mitomycin C. Retrovirus-like particles were demonstrated in cultured thymus cells in all cases of thymomas and thymus hyperplasias examined by electron microscopy. In most cases, these particles were detected in thymus epithelial cells. Reverse transcriptase activity sedimenting at a density of 1.15-1.17 gm/cm3 in sucrose density gradients was eluted in the culture fluids. Retrovirus-like particles were demonstrated in human T cells infected with these particles. Antibodies to virus-infected T cells were detected in sera of the patients with thymoma and thymus hyperplasia. These results suggest that in thymomas and thymus hyperplasias, retroviruses that can be induced, following a proliferative stimulus, may be involved in the genesis of thymic disorders and in the pathogenesis of systemic immunological diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414838     DOI: 10.1002/ssu.2980010305

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  3 in total

1.  Pure red cell aplasia associated with malignant thymoma, myasthenia gravis, polyclonal large granular lymphocytosis and clonal thymic T cell expansion.

Authors:  S I Handa; K P Schofield; M Sivakumaran; M Short; R S Pumphrey
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

Review 2.  Viral infection in thymoma and thymic tumors with autoimmune diseases.

Authors:  Rui Chang; Shuning Duan; Shicong Li; Peng Zhang
Journal:  Thorac Cancer       Date:  2021-09-17       Impact factor: 3.500

3.  Considerations for subgroups and phenocopies in complex disease genetics.

Authors:  Ryan Ramanujam; S Ramanujam; Jan Hillert
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.